Galvez-markov network transferability indices: Review of classic theory and new model for perturbations in metabolic reactions

Current Drug Metabolism

Volumn 15, Issue 5, 2014, Pages 557-564

  Vergara Galicia, Jorge ^a,b   Prado Prado, Francisco J ^a   González Díaz, Humberto ^b,c  

^a UNIVERSIDAD DE QUINTANA ROO   (Mexico)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

Complex networks; Markov chains; Metabolic networks; QSAR; Topological indices

Indexed keywords

ENZYME INHIBITOR; BACTERIAL PROTEIN; CAENORHABDITIS ELEGANS PROTEIN;

CALCULATION; GALVEZ CHARGE TRANSFER INDEX; GALVEZ MARKOV NETWORK TRANSFERABILITY INDEX; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; METABOLISM; PROBABILITY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTITATIVE STRUCTURE PROPERTY RELATION; REVIEW; THEORETICAL MODEL; THEORETICAL SAMPLE; WORKFLOW; ANIMAL; CHEMICAL STRUCTURE;

ANIMALS; BACTERIAL PROTEINS; CAENORHABDITIS ELEGANS PROTEINS; MARKOV CHAINS; METABOLIC NETWORKS AND PATHWAYS; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84925703267     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200215666140605125827     Document Type: Review

References (46)

1. Boccaletti, S.; Latora, V.; Moreno, Y.; Chavez, M.; Hwang, D.U. Complex networks: Structure and dynamics. Phys. Rep., 2006, 424, 175-308
2. Bonchev, D. On the complexity of directed biological networks. SAR QSAR Environ. Res., 2003, 14(3), 199-214
3. Bornholdt, S.; Schuster, H.G. Handbook of Graphs and Complex Networks: From the Genome to the Internet. WILEY-VCH GmbH & CO. KGa.: Wheinheim, 2003
4. Breiger, R. In Handbook of Data Analysis. Hardy, M.; Bryman, A., Eds.; Sage Publications: London, 2004, pp 505-526
5. Basak, S.C.; Balaban, A.T.; Grunwald, G.D.; Gute, B.D. Topological indices: Their nature and mutual relatedness. J. Chem. Inf. Comput. Sci., 2000, 40(4), 891-898
6. Devillers, J.; Balaban, A.T. Topological Indices and Related Descriptors in QSAR and QSPR. Gordon and Breach: The Netherlands, 1999
7. Estrada, E.; Uriarte, E. Recent advances on the role of topological indices in drug discovery research. Curr. Med. Chem., 2001, 8, 1573-1588
8. Gonzalez-Diaz, H.; Vilar, S.; Santana, L.; Uriarte, E. Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices. Curr. Top. Med. Chem., 2007, 7(10), 1015-1029
9. Chou, K.C. Graphic rule for drug metabolism systems. Curr Drug Metab, 2010, 11, (4), 369-378
10. Garcia, I.; Diop, Y.F.; Gomez, G. QSAR & complex network study of the HMGR inhibitors structural diversity. Curr. Drug Metab., 2010, 11(4), 307-314
11. Gonzalez-Diaz, H. Network topological indices, drug metabolism, and distribution. Curr. Drug Metab., 2010, 11(4), 283-284
12. Gonzalez-Diaz, H.; Duardo-Sanchez, A.; Ubeira, F.M.; Prado- Prado, F.; Perez-Montoto, L.G.; Concu, R.; Podda, G.; Shen, B. Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers. Curr. Drug Metab., 2010, 11(4), 379-406
13. Khan, M.T. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches. Curr. Drug Metab., 2010, 11(4), 285-295
14. Mrabet, Y.; Semmar, N. Mathematical methods to analysis of topology, functional variability and evolution of metabolic systems based on different decomposition concepts. Curr. Drug Metab., 2010, 11(4), 315-341
15. González-Díaz, H.; González-Díaz, Y.; Santana, L.; Ubeira, F.M.; Uriarte, E. Proteomics, networks and connectivity indices. Proteomics, 2008, 8, 750-778
16. Gálvez, J.; García, R.; Salabert, M.T.; Soler, R. Charge indexes. New topological descriptors. J. Chem. Inf. Comput. Sci., 1994, 34, 520-525
17. Prabhakar, Y.S.; Rawal, R.K.; Gupta, M.K.; Solomon, V.R.; Katti, S.B. Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones. Comb. Chem. High Throughput Screen, 2005, 8(5), 431-437
18. Fernandez, M.; Caballero, J.; Helguera, A.M.; Castro, E.A.; Gonzalez, M.P. Quantitative structure-activity relationship to predict differential inhibition of aldose reductase by flavonoid compounds. Bioorg. Med. Chem., 2005, 13(9), 3269-3277
19. Garcia-Domenech, R.; Galvez, J.; de Julian-Ortiz, J.V.; Pogliani, L. Some new trends in chemical graph theory. Chem. Rev., 2008, 108(3), 1127-1169
20. Sobarzo-Sanchez, E.; García-Pintos, I.; Fall, Y.; Gomez, G.; Santana, L.; Uriarte, E.; García-Mera, X.; Yañez, M.; Prado-Prado, F.J.; Vergara-Galicia, J.; González-Díaz, H. Galvez's topological indices model for multi-target enzyme inhibitors of neurodegenerative diseases. Curr. Top. Med. Chem., 2014, 14, in press
21. Winn, V.D.; Gormley, M.; Paquet, A.C.; Kjaer-Sorensen, K.; Kramer, A.; Rumer, K.K.; Haimov-Kochman, R.; Yeh, R.F.; Overgaard, M.T.; Varki, A.; Oxvig, C.; Fisher, S.J. Severe preeclampsia- related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology, 2009, 150(1), 452-462
22. Hill, T.; Lewicki, P. STATISTICS Methods and Applications. A Comprehensive Reference for Science, Industry and Data Mining. StatSoft: Tulsa, 2006
23. Riera-Fernandez, P.; Munteanu, C.R.; Dorado, J.; Martin-Romalde, R.; Duardo-Sanchez, A.; Gonzalez-Diaz, H. From chemical graphs in computer-aided drug design to general Markov-Galvez indices of drug-target, proteome, drug-parasitic disease, technological, and social-legal networks. Curr. Comput. Aided Drug Des., 2011, 7(4), 315-337
24. Gonzalez Diaz, H.; Olazabal, E.; Castanedo, N.; Sanchez, I.H.; Morales, A.; Serrano, H.S.; Gonzalez, J.; de Armas, R.R. Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer aided molecular design II: Experimental and theoretical assessment of a novel method for virtual screening of fasciolicides. J. Mol. Model., 2002, 8(8), 237-245
25. Gonzalez-Diaz, H.; Torres-Gomez, L.A.; Guevara, Y.; Almeida, M.S.; Molina, R.; Castanedo, N.; Santana, L.; Uriarte, E. Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design III: 2.5D indices for the discovery of antibacterials. J. Mol. Model., 2005, 11(2), 116-123
26. Gonzalez-Diaz, H.; Prado-Prado, F.; Ubeira, F.M. Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Curr. Top. Med. Chem., 2008, 8(18), 1676-1690
27. Estrada, E.; Rodriguez-Velazquez, J.A. Subgraph centrality in complex networks. Phys. Rev. E, 2005, 71(5 Pt 2), 056103
28. Estrada, E.; Bodin, O. Using network centrality measures to manage landscape connectivity. Ecol. Appl., 2008, 18(7), 1810-1825
29. Riera-Fernández, P.; Munteanu, C.R.; Pedreira-Souto, N.; Duardo- Sanchez, A.; González-Díaz, H. Definition of Markov-Harary Invariants and Review of Classic Topological Indices and Databases of Biology, Parasitology, Technology, and Social-Legal Networks. Curr. Bioinformatics, 2011, 6(1), 94-121
30. Gonzalez-Diaz, H.; Arrasate, S.; Gomez-San Juan, A.; Sotomayor, N.; Lete, E.; Besada-Porto, L.; Ruso, J.M. New Theory for Multiple Input-Output Perturbations in Complex Molecular Systems. 1. Linear QSPR Electronegativity Models in Physical, Organic, and Medicinal Chemistry. Curr. Top. Med. Chem., 2013
31. Box, G.E.P.; Jenkins, G.M. Time series analysis. Holden-Day, 1970
32. Luan, F.; Cordeiro, M.N.; Alonso, N.; Garcia-Mera, X.; Caamano, O.; Romero-Duran, F.J.; Yanez, M.; Gonzalez-Diaz, H. TOPSMODE model of multiplexing neuroprotective effects of drugs and experimental-Theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases. Bioorg. Med. Chem., 2013, 21, (7), 1870-1879
33. Tenorio-Borroto, E.; Garcia-Mera, X.; Penuelas-Rivas, C.G.; Vasquez-Chagoyan, J.C.; Prado-Prado, F.J.; Castanedo, N.; Gonzalez- Diaz, H. Entropy Model For Multiplex Drug-Target Interaction Endpoints Of Drug Immunotoxicity. Curr. Top. Med. Chem., 2013
34. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N. A ligand-based approach for the in silico discovery of multi-target inhibitors for proteins associated with HIV infection. Mol. Biosyst., 2012, 8(8), 2188-2196
35. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N. In Eur. J. Pharm. Sci., 2012 Elsevier B.V: Netherlands, 2012; Vol. 47, pp 273-279
36. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N. In Comb. Chem. High Throughput Screen: Netherlands, 2012; Vol. 15, pp 666-673
37. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N. In Ecotoxicol Environ Saf; 2012 Elsevier Inc: United States, 2012; Vol. 80, pp 308-313
38. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N. In Bioorg. Med. Chem; 2012 Elsevier Ltd: England, 2012; Vol. 20, pp 4848-4855
39. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N. Multi-target drug discovery in anti-cancer therapy: Fragment-based approach toward the design of potent and versatile anti-prostate cancer agents. Bioorg. Med. Chem., 2011, 19(21), 6239-6244
40. Gonzalez-Diaz, H.; Arrasate, S.; Gomez-Sanjuan, A.; Sotomayor, N.; Lete, E.; Besada-Porto, L.; Ruso, J.M. General Theory for Multiple Input-Output Perturbations in Complex Molecular Systems. 1. Linear QSPR Electronegativity Models in Physical, Organic, and Medicinal Chemistry. Curr. Top. Med. Chem., 2013, 13(14), 1713-1741
41. González-Díaz, H.; Pérez-Montoto, L.G.; Ubeira, F.M. Model for Vaccine Design by Prediction of B-Epitopes of IEDB given Perturbations in Peptide Sequence, In vivo Process, Experimental Techniques, and Source or Host Organisms. Clin. Develop. Immunol., 2014, 2014, 1-20
42. Jeong, H.; Tombor, B.; Albert, R.; Oltvai, Z.N.; Barabasi, A.L. The large-scale organization of metabolic networks. Nature, 2000, 407(6804), 651-654
43. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N. Chemoinformatics in anti-cancer chemotherapy: Multi-target QSAR model for the in silico discovery of anti-breast cancer agents. Eur. J. Pharm. Sci., 2012, 47(1), 273-279
44. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N. Unified Multi-target Approach for the Rational in silico Design of Anti-bladder Cancer Agents. Anticancer Agents Med. Chem., 2013, 13(5), 791-800
45. Speck-Planche, A.; Kleandrova, V.V.; Cordeiro, M.N. New insights toward the discovery of antibacterial agents: Multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs. Eur. J. Pharm. Sci., 2013, 48(4-5), 812-818
46. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N. Multi-target inhibitors for proteins associated with Alzheimer: In silico discovery using fragment-based descriptors. Curr. Alzheimer Res., 2013, 10(2), 117-124.